6 Months Exclusive Breast Feeding for Mothers with HIV Lowers Transmission Rates

6 Months Exclusive Breast Feeding for Mothers with HIV Lowers Transmission Rates

0:00

HOOSEN COOVADIA, University of KwaZulu-Natal, Durban REFERENCE: Abstract 13, 14th Conference on Retroviruses and Opportunistic Infections, Los Angeles February 25-28, 2007 In the developing world brea

Hoosen Coovadia

HOOSEN COOVADIA, University of KwaZulu-Natal, Durban

REFERENCE: Abstract 13, 14th Conference on Retroviruses and Opportunistic Infections, Los Angeles February 25-28, 2007In the developing world breastfeeding is the recommended infant feeding method, even for women infected with HIV. While early cessation of breastfeeding reduces HIV transmission to the baby, studies have shown that it increases morbidity and mortality in the infants. Exclusive breastfeeding for the first six months of life appears to reduce HIV transmission, as opposed to “mixed” breastfeeding with supplementation with formula or solid foods. Dan Keller spoke withHoosen Coovadia, who delivered a plenary talk on the subject at the14th Conference on Retroviruses and Opportunistic Infections in Los Angeles.

Related Episodes

London School of Hygiene & Tropical Medicine Audio News – Undernutrirtion Causes a Third of Child Deaths

London School of Hygiene & Tropical Medicine Audio News – Undernutrirtion Causes a Third of Child Deaths

Zulfiqar Bhutta Reference: The Lancet, Maternal and Child Undernutrition Special Series With one child in three killed by it, childhood and maternal undernutrition are discussed in a special series of

Which HIV Treatment is Best for Patients with HIV and Hepatitis C?

Which HIV Treatment is Best for Patients with HIV and Hepatitis C?

Juan Berenguer REFERENCE: Abstract V-1385, 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, 2007 JUAN BERENGUER, Hospital Gregorio Marañón, Madrid A ret

Entecavir for Hepatitis B Linked to HIV Resistance

Entecavir for Hepatitis B Linked to HIV Resistance

Moira McMahon REFERENCE:47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, 2007 MOIRA MCMAHON, Johns Hopkins University, Baltimore The hepatitis B drug ente